Medical Publications
I am currently the lead and corresponding author of 18 peer reviewed, PubMed indexed medical publications across Dermatology, Obstetric Anesthesia, Global and Public Health, Opioid Use Disorder, and Postsurgical Pain.
Dermatology
My work in dermatology began during a shadowing experience where I encountered patients with severe alopecia areata and atopic dermatitis. This exposure led to research collaborations with board certified dermatologists Drs. Mehta and Soliman in Las Vegas, and with Dr. Rajpara, Professor and Chair of Dermatology at the University of Missouri-Kansas City School of Medicine. These experiences shaped my early interest in inflammatory skin disease and contributed to multiple peer reviewed publications.
- 1 Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- 2 Biologic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Bayesian Network Meta-Analysis of Established and Investigational Agents
- 3 Upadacitinib Leads in Efficacy: A Bayesian Network Meta-Analysis of Four JAK Inhibitors in Moderate-To-Severe Atopic Dermatitis
- 4 Comparative Efficacy of Upadacitinib, Baricitinib, and Ritlecitinib in Adolescents With Severe Alopecia Areata: A Systematic Review and Bayesian Network Meta-Analysis
- 5 Placeholder Article Title Five
- 6 Placeholder Article Title Six
Obstetric Anesthesia
Spinal anesthesia is the technique of choice for cesarean delivery, yet it carries a high risk of postspinal hypotension, which can result in maternal and fetal complications. My research examined the comparative efficacy of phenylephrine, norepinephrine, and epinephrine for preventing and treating postspinal hypotension in both elective and emergency cesarean delivery. This work culminated in five peer reviewed publications and was conducted in collaboration with Professors Free and Desai in the Department of Obstetrics and Gynecologic Surgery at the UNLV School of Medicine, and Dr. Ashraf, Director of Critical Care Services at MountainView Hospital. My motivation for this research was personal: my mother experienced complications related to hypotension while delivering both me and my younger brother.
- 1Therapeutic Vasopressor Use for Postspinal Hypotension in Low-Risk Elective Cesarean Deliveries: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis
- 2Intraoperative Hypotension After Neuraxial Anesthesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Vasopressors for Cesarean Birth Stratified by Maternal Risk
- 3Prevention of Post-Spinal Hypotension in High Risk Cesarean Delivery: A Systematic Review and Updated Network Meta-Analysis of Prophylactic Vasopressor Infusions
- 4Comparative Effectiveness of Prophylactic Vasopressors During Elective Cesarean Delivery Under Neuraxial Anesthesia: A Systematic Review With Network-Based Quantitative Synthesis
- 5Maternal and Fetal Outcomes of Phenylephrine Bolus versus Infusion during Cesarean Delivery: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis
Global/Public Health
My interest in global health began during a reluctant trip to the highlands of Sumatra, Indonesia, where I first observed adults with massively swollen lower limbs caused by lymphatic filariasis. This experience inspired me to found the Society for Awareness of Neglected Diseases (SAND), a student led nonprofit focused on raising awareness of neglected tropical diseases. Around the same time, I became aware of significant reductions in funding for the FDA, NIH, and CDC, as well as the dismantling of USAID and the U.S. withdrawal from the WHO. These developments motivated me to write several editorials on global and public health policy.
- 1Reclaiming Rural Medicine: Mass Drug Administration, Community Sovereignty, and Institutional Memory
- 2China's Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership
- 3Placeholder Article Title Three
- 4Reply to Gottlieb: The Bogeyman Narrative Undermines U.S. Pharmaceutical Innovation
- 5Reply to Gottlieb: Making the FDA Great Again Requires Rebuilding the Rest of US Science
Opioid Use Disorder
Opioid use disorder (OUD) remains a devastating condition, yet structural barriers continue to limit access to effective medications. Although strong evidence demonstrates that buprenorphine is safe and effective for youth, adolescents remain the age group least likely to receive medication treatment for OUD. My interest in this field was shaped by the concept of medication based recovery, introduced by Dr. Nora Volkow, Director of the National Institute on Drug Abuse, in the New England Journal of Medicine. Additional motivation came from a JAMA Pediatrics study by Dr. Robert Kleinman, which demonstrated significantly lower overdose risk, longer treatment retention, and no deaths among adolescents treated with buprenorphine compared with methadone. These insights led us to write what may be the most comprehensive and up to date review on buprenorphine for adolescent OUD.
Postsurgical Pain
Although opioid analgesics remain the standard of care for short term postsurgical pain, concerns persist regarding safety, tolerability, and addiction risk. In collaboration with Dr. Gill of University College Hospital London and Dr. Ashraf of MountainView Hospital, I reported research on intravenous formulations of ketoprofen and tramadol that are widely used internationally but not available in the United States or Canada. This work contributes to ongoing discussions about expanding non opioid analgesic options in perioperative care.
- 1Seizures Following Single-Dose Intravenous Tramadol for Postsurgical Pain: A Report of Two Cases
- 2Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Comparison of the Analgesic Efficacy and Safety of Intravenous Ketoprofen, Tramadol, and Morphine After Bony Impacted Mandibular Third Molar Surgery